Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Notice of Proposed Sale · 144

ResMed Inc.

Notice of Proposed Sale

Filed Jul 7, 2026Accepted Jul 7, 2026, 10:07 AM EDTFiling CIK 943819Accession 0001959173-26-005132
Share

Structured filing — 144

primary_doc.xml

Open full document ↗

Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.

Proposed-sale notice

Issuer
RESMED INC
Issuer CIK
0000943819
SEC file number
001-15317
Phone
8587462400
Person for whose account securities are to be sold
Farrell Michael J.
Relationships to issuer
Officer · Director
Street
9001 SPECTRUM CENTER BLVD.
City
SAN DIEGO
State / country code
CA
Postal code
92123

Securities proposed for sale

Securities proposed for sale · 1 reported row
SecurityProposed unitsAggregate market valueUnits outstandingApproximate sale dateExchangeBroker / market maker
Common4,9911,094,725.94145,056,38407/07/2026NYSEFidelity Brokerage Services LLC

Broker / market maker — proposed row 1, entry 1

Name
Fidelity Brokerage Services LLC
Street
900 Salem Street
City
Smithfield
State / country code
RI
Postal code
02917

Acquisition of securities to be sold

Acquisition of securities to be sold · 1 reported row
SecurityAcquiredNature of acquisitionAcquired fromAmount acquiredGift transactionPayment dateNature of payment
Common07/07/2026Stock Option ExerciseIssuer4,991N07/07/2026Cash

Sales reported in the preceding three months

Sales reported in the preceding three months · 3 reported rows
SellerSecuritySale dateAmount soldGross proceeds
Michael FarrellCommon04/07/20264,9911,125,486.47
Michael FarrellCommon05/07/20264,9911,037,232.61
Michael FarrellCommon06/08/20264,991968,064.34

Seller — prior-sale row 1, entry 1

Name
Michael Farrell
Street
9001 Spectrum Center Blvd.
City
San Diego
State / country code
CA
Postal code
92123

Seller — prior-sale row 2, entry 1

Name
Michael Farrell
Street
9001 Spectrum Center Blvd.
City
San Diego
State / country code
CA
Postal code
92123

Seller — prior-sale row 3, entry 1

Name
Michael Farrell
Street
9001 Spectrum Center Blvd.
City
San Diego
State / country code
CA
Postal code
92123

Prior-sale reporting

Nothing to report for the preceding three months
N

Notice signature

Notice date
07/07/2026
Signed
/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Michael Farrell
Plan adoption dates
10/31/2024

Company context

Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.

Current securities

Recent company filings

  1. 10-Q filingOct 30, 2026
  2. Results of Operations and Financial Condition · Other EventsOct 29, 2026
  3. ARS filingOct 1, 2026
  4. DEFA14A filingOct 1, 2026
  5. DEF 14A filingOct 1, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.